Summary: In 43 adults with type 2 diabetes in English primary care, a nested qualitative process evaluation of the SuMMiT-D SMS text-messaging intervention used inductive thematic analysis to explore experiences rather than to measure adherence. Two overarching themes emerged: the messages were perceived to deliver wide-ranging, sometimes unexpected holistic benefits, and their perceived value was fluid and shaped by personal context. No quantitative adherence outcome and no statistical significance testing were reported in this paper.
PICO Summary
| Element | Detail |
|---|---|
| Population | 43 adults with type 2 diabetes on oral glucose-lowering, blood-pressure-lowering, or lipid-lowering treatment; nested qualitative process study within the SuMMiT-D randomised controlled trial; primary care, England. |
| Intervention | SuMMiT-D evidence-based SMS text-messaging intervention to support regular, consistent diabetes medication use; participants interviewed by semistructured telephone interview (single arm sampled for interviews). |
| Comparison | No within-study comparator; this is a qualitative process evaluation, not a controlled effectiveness comparison (effectiveness is reported separately by the parent trial). |
| Outcome | Qualitative themes only, no effect size, 95% CI, p value, ARR, or NNT. Two overarching themes: (1) the system exerted a range of holistic benefits and supported the cognitions, beliefs, and behaviours needed for longitudinal self-management; (2) perceived value was fluid and tied to contextual need, influenced by existing routines, lifestyle disruption, understanding of type 2 diabetes, relationships, and attitudes toward living with the condition. Many participants reported wide-ranging, unexpected benefits, challenging assumptions about who appraises such systems positively. |
Expert Commentary
This is a qualitative process evaluation nested within the SuMMiT-D randomised controlled trial, and it should be read as such. No adherence rate was measured here, no comparator arm was analysed, and no significance testing was performed, so the work cannot establish that text messaging improves medication taking. What it does well is map how 43 patients experienced the intervention and why their appraisals varied, generating hypotheses about mechanisms of change rather than proof of effect. The themes are plausible and clinically resonant: messages were valued for holistic, longitudinal engagement with health, and their usefulness was shaped by routines, life disruption, illness understanding, and relationships. The headline that benefits were unexpected and widely distributed is a useful corrective to assumptions about who is offered such tools, but it is an interpretive claim from interview data, not an outcome. The main limitation is selection and recall, because interviewees were drawn from those willing to be interviewed and may over-represent engaged users, and the analysis is interview-dependent. Can I use this with my patients? Not yet as evidence that SMS support improves adherence, that question belongs to the parent trial’s effectiveness results; it is reasonable, however, to use these findings to inform how messaging is framed and offered. I would wait for, and read, the SuMMiT-D primary outcome before drawing efficacy conclusions.
References
Newhouse N, Bartlett YK, Simao SC, Miles L, Cholerton R, Kenning C, et al. Experiences of using a digital text messaging intervention to support oral medication adherence for people living with type 2 diabetes: qualitative process evaluation. J Med Internet Res. 2025;27:e70203. doi:10.2196/70203